Fig. 9

Efficacy of top-2 gene signatures, OAS1 and ISG15, in differentiating mock-infected samples from various EBOV strains: (a) wild-type (wt), (b) VP35m, (c) VP24m, and (d) double mutant VP35m&VP24m, evaluated on the held-out test set
Efficacy of top-2 gene signatures, OAS1 and ISG15, in differentiating mock-infected samples from various EBOV strains: (a) wild-type (wt), (b) VP35m, (c) VP24m, and (d) double mutant VP35m&VP24m, evaluated on the held-out test set